Sfoglia per AUTORE
MARCHESELLI L
Collezione ASL Biella

  

Items : 6

End of induction [(18)F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3311-3321. doi: 10.1007/s00259-024-06765-z. Epub 2024 Ma

2024
ASL Biella
AOU Alessandria

Versari A; Luminari S; Pennese E; Perrone T; Liberati AM; Stefani PM; Ibatici A; Usai SV; Falcinelli F; Vitolo U; Gini G; Roti G; Galimberti S; Musto P; Mannina D; Conconi A; Bari A; Massaia M; Califano C; Chiarenza A; Arcari A; Pavone V; Bianchi B; Bolis SAM; Musuraca G; Tosi P; Barbieri E; Ladetto M; Monaco L; et alii...

Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi. in Hematological oncology / Hematol Oncol. 2023 Oct;41(4):655-662. doi: 10.1002/hon.3184. Epub 2023 May 28.

2023
AO Cuneo
ASL Biella

Gini G; Federico M; Luminari S; Marcheselli L; Catellani H; Skrypets T; Stefani PM; Pastore D; Pennese E; Liberati AM; Ballerini F; Vitolo U; Usai SV; Capponi M; Galimberti S; Perrone T; Re F; Mannina D; Musto P; Conconi A; Bari A; Massaia M; Ghiggi C; Pulsoni A; Musuraca G; Califano C; Merli M; Manni M; Nizzoli ME; et alii...

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

2022
ASL Torino 5
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara
AOU Alessandria

Merli F; Cattaneo C; Bonuomo V; Busca A; Ferreri AJM; Bruna R; Petrucci L; Cairoli R; Bertù L; Passamonti F; Corradini P; Krampera M; Lanza F; Candoni A; Conconi A; Tosi P; Selleri C; Venditti A; Corso A; Armiento D; Rigacci L; La Barbera EO; Gambacorti-Passerini C; Visani G; Vallisa D; Cardinali V; Cilloni D; Galimberti S; Bocchia M; et alii...

Impact of Immunochemotherapy with R-Bendamustine or R-CHOP in the Post-Induction Management of Treatment Naïve Advanced Stage Follicular Lymphoma Patients: A Subset Analysis of the FOLL12 Trial By the Fondazione Italiana Linfomi (FIL) in Blood

2021
AOU Città della Salute di Torino
ASL Biella

Luminari S; Nizzoli ME; Chiarenza A; Mannina D; Tucci A; Boccomini C; Farina L; Olivieri J; Marcheselli L; Ferrero S; Arcaini L; Pulsoni A; Musuraca G; Califano C; Merli M; Bari A; Conconi A; Re F; Balzarotti M; Ladetto M; Patti C; Pinto A; Cabras MG; Musto P; Gini G; Arcari A; Manni M; Versari A; Federico M; et alii...

RESPONSE ADAPTED POST INDUCTION THERAPY IN FOLLICULAR LYMPHOMA: UPDATED RESULTS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL) in Haematologica

2021
ASL Biella

Luminari S; Galimberti S; Versari A; Tucci A; Boccomini C; Farina L; Zaja F; Marcheselli L; Ferrero S; Arcaini L; Pulsoni A; Musuraca G; Califano C; Merli M; Bari A; Conconi A; Del Giudice I; Re F; Stefani PM; Usai SV; Perrone T; Gini G; Falini B; Gattei V; Manni M; Ladetto M; Mannina D; Federico M;

Outcome of diffuse large B-cell lymphoma associated with hepatitis c virus in elderly patients: Results of the prospective “elderly project” by the fondazione italiana linfomi (FIL) in HemaSphere

2020
ASL Biella
ASL Asti
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Mammi C; Luminari S; Marcheselli L; Marino D; Arcaini L; Tarantini G; Pozzi S; Di Rocco A; Re F; Flenghi L; Sartori R; Cabras MG; Tani M; Puccini B; Ladetto M; Chiappella A; Nassi L; Vallisa D; Angrilli F; Arcari A; Gini G; Zilioli VR; Spina M; Merli M; Balzarotti M; Fabbri A; Cavallo F; Ghentile M; Merli F; et alii...